We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRDS
3901
DELISTED
Bird Global, Inc.
BRDS
$58K ﹤0.01%
+939
New +$83.4K
YELL
3902
DELISTED
Yellow Corporation Common Stock
YELL
$58K ﹤0.01%
+8,246
New +$78.6K
NVVE
3903
DELISTED
Nuvve Holding Corp
NVVE
0
LILM
3904
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$57K ﹤0.01%
+14,355
New +$66.3K
AUD
3905
DELISTED
Audacy, Inc.
AUD
$57K ﹤0.01%
+19,764
New +$52.2K
BSRR icon
3906
Sierra Bancorp
BSRR
$528M
$56K ﹤0.01%
2,279
-14,765
-87% -$394K
PRAX icon
3907
Praxis Precision Medicines
PRAX
$8.58B
$56K ﹤0.01%
+367
New +$75.4K
SIGA icon
3908
SIGA Technologies
SIGA
$235M
$56K ﹤0.01%
8,040
-50,521
-86% -$338K
XERS icon
3909
Xeris Biopharma Holdings
XERS
$1.39B
$56K ﹤0.01%
+21,788
New +$53.2K
XGN icon
3910
Exagen
XGN
$109M
$56K ﹤0.01%
+7,066
New +$60.9K
VRN
3911
DELISTED
Veren
VRN
$56K ﹤0.01%
7,721
-10,280
-57% -$69.4K
CMRX
3912
DELISTED
Chimerix, Inc.
CMRX
$56K ﹤0.01%
12,193
-76,413
-86% -$426K
MRNS
3913
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$56K ﹤0.01%
+5,996
New +$59.6K
SGII
3914
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$56K ﹤0.01%
+5,700
New +$56.2K
AMTX icon
3915
Aemetis
AMTX
$106M
$55K ﹤0.01%
4,390
-28,426
-87% -$313K
AVNW icon
3916
Aviat Networks
AVNW
$265M
$55K ﹤0.01%
1,776
-11,489
-87% -$335K
BLBD icon
3917
Blue Bird Corp
BLBD
$2.35B
$55K ﹤0.01%
2,915
-16,267
-85% -$296K
DAWN
3918
DELISTED
Day One Biopharmaceuticals
DAWN
$55K ﹤0.01%
+5,487
New +$72.5K
FRST icon
3919
Primis Financial Corp
FRST
$399M
$55K ﹤0.01%
+3,919
New +$57.9K
LEU icon
3920
Centrus Energy
LEU
$3.48B
$55K ﹤0.01%
1,626
-10,151
-86% -$426K
TNYA icon
3921
Tenaya Therapeutics
TNYA
$161M
$55K ﹤0.01%
+4,642
New +$56.2K
DICE
3922
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$55K ﹤0.01%
+2,861
New +$51.1K
WQGA
3923
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
$55K ﹤0.01%
+5,600
New +$55.1K
BNFT
3924
DELISTED
Benefitfocus, Inc.
BNFT
$55K ﹤0.01%
4,240
-26,134
-86% -$279K
ACT icon
3925
Enact Holdings
ACT
$6.61B
$54K ﹤0.01%
+2,400
New +$51.8K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.